Hiroko Nobuta
- Developmental Neuroscience top 1%
- Neurogenesis and neuroplasticity mechanisms 4
- Neurology top 2%
- Neuroinflammation and Neurodegeneration Mechanisms 3
-
- Neuropeptides and Animal Physiology 6
- Biological Psychiatry top 10%
-
- Neonatal and fetal brain pathology 3
-
- Neonatal Respiratory Health Research 3
-
- Chemokine receptors and signaling 2
-
- Cancer, Stress, Anesthesia, and Immune Response 2
-
- Immune Response and Inflammation 2
- Co-authors
- James A. WaschekCatalina AbadDavid H. RowitchAri GreenFeng MeiJonah R. ChanRoland G. HenryCarolyn Bevan
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Hiroko Nobuta
21 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Developmental Neuroscience 379
- Neurology 381
- Cellular and Molecular Neuroscience 455
- Biological Psychiatry 35
- Pathology and Forensic Medicine 238
Countries citing papers authored by Hiroko Nobuta
This map shows the geographic impact of Hiroko Nobuta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Nobuta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Nobuta more than expected).
Fields of papers citing papers by Hiroko Nobuta
This network shows the impact of papers produced by Hiroko Nobuta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Nobuta. The network helps show where Hiroko Nobuta may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hiroko Nobuta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 11 | |
| 2 | 2020 | 128 | |
| 3 | 2019 | 85 | |
| 4 | 2018 | 8 | |
| 5 | Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trialbreakdown → | 2017 | 393 |
| 6 | 2017 | 93 | |
| 7 | 2016 | 92 | |
| 8 | 2015 | 37 | |
| 9 | 2014 | 57 | |
| 10 | 2013 | 23 | |
| 11 | 2013 | 45 | |
| 12 | 2012 | 24 | |
| 13 | 2012 | 78 | |
| 14 | 2010 | 39 | |
| 15 | 2009 | 6 | |
| 16 | 2007 | 38 | |
| 17 | 2007 | 96 | |
| 18 | 2007 | 49 | |
| 19 | 2006 | 56 | |
| 20 | 2005 | 50 |
About Hiroko Nobuta
Hiroko Nobuta is a scholar working on Developmental Neuroscience, Cellular and Molecular Neuroscience, Neurology, Biological Psychiatry and Immunology, having authored 21 papers that have together received 1.5k indexed citations. Recurring topics across this work include Neuropeptides and Animal Physiology (6 papers), Neurogenesis and neuroplasticity mechanisms (4 papers), Neonatal and fetal brain pathology (3 papers), Neonatal Respiratory Health Research (3 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers), Chemokine receptors and signaling (2 papers), Cancer, Stress, Anesthesia, and Immune Response (2 papers) and Immune Response and Inflammation (2 papers). The work is most often cited by research in Developmental Neuroscience (379 citations), Neurology (381 citations), Cellular and Molecular Neuroscience (455 citations), Biological Psychiatry (35 citations) and Pathology and Forensic Medicine (238 citations). Hiroko Nobuta has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include James A. Waschek, Catalina Abad, David H. Rowitch, Ari Green, Feng Mei, Jonah R. Chan, Roland G. Henry, Carolyn Bevan, Roy Gerona and W. John Boscardin. Their work appears in journals such as Neuroscience, Neuron, Behavioral Neuroscience, Journal of Leukocyte Biology and Acta Neuropathologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.